SCHEMBL2480116

SCHEMBL2480116

CCOC(=O)NCC1COC(=O)N1c1cc(F)c(N2CCN(C(=O)OC(C)(C)C)CC2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CYP2C19 P33261 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
HTT P42858 3/20 0.36
MAPT P10636 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP2 O75604 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
ALOX15 P16050 2/20 0.36
TP53 P04637 2/20 0.36
ALOX12 P18054 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
DPP4 P27487 1/20 0.35
MAPK1 P28482 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2503392 0.93 GPR119 (0.37) ALDH1A1MEN1KMT2ASMN1; SMN2CYP2C19
SCHEMBL2452755 0.91 MAOA (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2CYP2C19
SCHEMBL2486343 0.90 GPR119 (0.37) MEN1KMT2ASMN1; SMN2CYP2C19GPR119
SCHEMBL2498576 0.86 HPGD (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2GPR119
SCHEMBL2507043 0.86 GPR119 (0.41) ALDH1A1GPR119MAPTLMNADPP4
SCHEMBL2480377 0.85 GPR119 (0.40) ALDH1A1GPR119MAPTLMNADPP4
SCHEMBL2480112 0.85 MAOB (0.46) LMNA
SCHEMBL2504492 0.83 KDM4E (0.37) GPR119MAPTKDM4E
SCHEMBL2499942 0.82 GPR119 (0.39) GPR119
SCHEMBL2480117 0.82 MEN1 (0.41) ALDH1A1MEN1KMT2ACYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841306-B2 Antimicrobials PANACEA BIOTEC LTD. (IN) 2014-09-23 US disclosed
US-20110245258-A1 NOVEL ANTIMICROBIALS PANACEA BIOTEC LTD. (IN) 2011-10-06 US disclosed
EP-2367820-A2 Novel antimicrobials Panacea Biotec Limited (IN) 2011-09-28 EP disclosed
WO-2010058423-A2 NOVEL ANTIMICROBIALS PANACEA BIOTEC LTD. (IN) 2010-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245258-A1 NOVEL ANTIMICROBIALS ECI1, XDH, CYP3A4 ALDH1A1 665/4885MEN1 4061/4885KMT2A 4705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.